Template:Anthrax antibiotics: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) (Marked this version for translation) |
||
| Line 2: | Line 2: | ||
<translate> | <translate> | ||
====Postexposure Prophylaxis==== | ====Postexposure Prophylaxis==== <!--T:1--> | ||
<!--T:2--> | |||
''Patient should be vaccinated at day #0, #14, #28'' | ''Patient should be vaccinated at day #0, #14, #28'' | ||
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 500mg PO q12hrs daily x 60 days '''OR''' | *[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 500mg PO q12hrs daily x 60 days '''OR''' | ||
| Line 9: | Line 10: | ||
====Cutaneous Anthrax (not systemically ill)==== | ====Cutaneous Anthrax (not systemically ill)==== <!--T:3--> | ||
<!--T:4--> | |||
*Ciprofloxacin 500mg PO q12hrs x 60 days | *Ciprofloxacin 500mg PO q12hrs x 60 days | ||
*Doxycycline 100mg PO q12hrs x 60 days | *Doxycycline 100mg PO q12hrs x 60 days | ||
====Inhalation or Cutaneous with systemic illness==== | ====Inhalation or Cutaneous with systemic illness==== <!--T:5--> | ||
<!--T:6--> | |||
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 400mg IV q12hrs x 60 days (1st line) '''OR''' | *[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 400mg IV q12hrs x 60 days (1st line) '''OR''' | ||
*[[Special:MyLanguage/Doxycycline|Doxycycline]] 100mg IV q12hrs x 60days (only if allergic to ciprofloxacin) '''PLUS''' | *[[Special:MyLanguage/Doxycycline|Doxycycline]] 100mg IV q12hrs x 60days (only if allergic to ciprofloxacin) '''PLUS''' | ||
| Line 22: | Line 25: | ||
====Pediatric Postexpsoure Prophylaxis==== | ====Pediatric Postexpsoure Prophylaxis==== <!--T:7--> | ||
<!--T:8--> | |||
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 15mg/kg PO q12hrs x 60 days | *[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 15mg/kg PO q12hrs x 60 days | ||
*[[Special:MyLanguage/Doxycycline|Doxycycline]] 2.2mg/kg PO q12hrs x 60 days | *[[Special:MyLanguage/Doxycycline|Doxycycline]] 2.2mg/kg PO q12hrs x 60 days | ||
====Pediatric Cutaneous Anthrax (not ill)==== | ====Pediatric Cutaneous Anthrax (not ill)==== <!--T:9--> | ||
<!--T:10--> | |||
*Same as post exposure dosing and duration | *Same as post exposure dosing and duration | ||
====Pediatric Inhalational or Cutaneous (systemically ill==== | ====Pediatric Inhalational or Cutaneous (systemically ill==== <!--T:11--> | ||
<!--T:12--> | |||
*[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 15mg/kg IV q12hrs (1st line) '''OR''' | *[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 15mg/kg IV q12hrs (1st line) '''OR''' | ||
*[[Special:MyLanguage/Doxycycline|Doxycycline]] 2.2mg/kg IV q12hrs (only if allergic to cipro) '''PLUS''' | *[[Special:MyLanguage/Doxycycline|Doxycycline]] 2.2mg/kg IV q12hrs (only if allergic to cipro) '''PLUS''' | ||
**[[Special:MyLanguage/Clindamycin|Clindamycin]] 7.5mg/kg q6hrs daily | **[[Special:MyLanguage/Clindamycin|Clindamycin]] 7.5mg/kg q6hrs daily | ||
</translate> | </translate> | ||
Latest revision as of 09:00, 20 January 2026
Postexposure Prophylaxis
Patient should be vaccinated at day #0, #14, #28
- Ciprofloxacin 500mg PO q12hrs daily x 60 days OR
- Doxycycline 100mg PO q12hrs x 60 days
Cutaneous Anthrax (not systemically ill)
- Ciprofloxacin 500mg PO q12hrs x 60 days
- Doxycycline 100mg PO q12hrs x 60 days
Inhalation or Cutaneous with systemic illness
- Ciprofloxacin 400mg IV q12hrs x 60 days (1st line) OR
- Doxycycline 100mg IV q12hrs x 60days (only if allergic to ciprofloxacin) PLUS
- Clindamycin 900mg IV q8hrs
Pediatric Postexpsoure Prophylaxis
- Ciprofloxacin 15mg/kg PO q12hrs x 60 days
- Doxycycline 2.2mg/kg PO q12hrs x 60 days
Pediatric Cutaneous Anthrax (not ill)
- Same as post exposure dosing and duration
Pediatric Inhalational or Cutaneous (systemically ill
- Ciprofloxacin 15mg/kg IV q12hrs (1st line) OR
- Doxycycline 2.2mg/kg IV q12hrs (only if allergic to cipro) PLUS
- Clindamycin 7.5mg/kg q6hrs daily